Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study

Gastroenterology
Richard MoreauJean-Francois Cadranel

Abstract

Type 1 hepatorenal syndrome (HRS) is a severe complication of cirrhosis associated with a short median survival time (<2 weeks). Although the administration of terlipressin improves renal function, its effect on survival is unknown. This study investigated predictive factors of survival in patients with type 1 HRS treated with terlipressin. Ninety-nine patients with type 1 HRS treated with terlipressin in 24 centers were retrospectively studied. Terlipressin-induced improved renal function was defined as a decrease in serum creatinine value to <130 micromol/L or a decrease of at least 20% at the end of treatment. At inclusion, the Child-Pugh score was 11.8 +/- 1.6 (mean +/- SD). Terlipressin (3.2 +/- 1.3 mg/day) was administered for 11 +/- 12 days. Renal function improved in 58% of patients (serum creatinine decreased by 46% +/- 17% from 272 +/- 114 micromol/L). Median survival time was 21 days. Survival rate was 40% at 1 month. Multivariate analysis showed that improved renal function and Child-Pugh score < or =11 at inclusion were independent predictive factors of survival (P < 0.0001 and 0.02, respectively). Thirteen patients underwent liver transplantation (92 +/- 95 days after HRS onset), 10 of whom had received terlipress...Continue Reading

Citations

Jul 27, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Pere Ginès, Mónica Guevara
Jun 28, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Gilles Pomier-LayrarguesAlbert Tran
Sep 1, 2004·Alimentary Pharmacology & Therapeutics·S Møller, J H Henriksen
Sep 1, 2004·Alimentary Pharmacology & Therapeutics·D Lebrec
Jul 9, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Florence WongKenneth Sniderman
Sep 1, 2004·Alimentary Pharmacology & Therapeutics·P Angeli
Dec 29, 2004·Postgraduate Medicine·Wendy TongPaul H Hayashi
Jun 25, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Luis Ruiz-del-ArbolVicente Arroyo
Nov 30, 2005·Current Treatment Options in Gastroenterology·Bimaljit Singh Sandhu, Arun J Sanyal
Oct 27, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Paul E MarikThomas E Starzl
May 28, 2005·Digestive Diseases·Mónica Guevara, Pere Ginès
Mar 18, 2006·Current Opinion in Critical Care·Philip A Berry, Julia A Wendon
Sep 5, 2006·Alimentary Pharmacology & Therapeutics·F FabriziP Martin
Aug 26, 2006·Anesthesiology·Tanja A Treschan, Jürgen Peters
Jan 5, 2007·Nature Clinical Practice. Gastroenterology & Hepatology·Florence Wong
Nov 22, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Aleksander KragFlemming Bendtsen
Nov 1, 2008·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Gebhard WagenerDonald Landry
Dec 17, 2008·Expert Review of Gastroenterology & Hepatology·Fuat H SanerChristoph E Broelsch
Oct 1, 2009·Journal of Gastroenterology and Hepatology·Evangelos CholongitasAndrew K Burroughs
Oct 2, 2009·Pharmacotherapy·Tyree H KiserDouglas N Fish
May 29, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Bruce A Runyon, UNKNOWN AASLD Practice Guidelines Committee
Dec 3, 2009·European Journal of Gastroenterology & Hepatology·Christos K TriantosAndrew K Burroughs
Oct 31, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·André NazarPere Ginès
Jan 14, 2011·Journal of Gastroenterology and Hepatology·Harshal Rajekar, Yogesh Chawla
Aug 19, 2011·Digestive Diseases and Sciences·Marco Olivera-MartinezMarius C Florescu
Apr 23, 2013·Liver International : Official Journal of the International Association for the Study of the Liver·Saubhik GhoshVirendra Singh
Feb 20, 2013·The American Journal of Gastroenterology·Virendra SinghAshish Bhalla
Apr 23, 2013·Critical Care : the Official Journal of the Critical Care Forum·Bertrand SauneufFrédéric Pène
Nov 2, 2014·The American Journal of Case Reports·Banu Demet Ozel CoskunFatma Senel
Sep 29, 2015·World Journal of Hepatology·Paulo Lisboa BittencourtCarlos Terra
Nov 27, 2015·BMC Gastroenterology·Francesco SalernoMahlon M Wilkes
Dec 10, 2019·Current Opinion in Endocrinology, Diabetes, and Obesity·Arpan Mohanty
Nov 9, 2002·Alimentary Pharmacology & Therapeutics·S SenR Jalan
Feb 11, 2005·Current Opinion in Gastroenterology·Guadalupe Garcia-Tsao
Sep 1, 2004·Alimentary Pharmacology & Therapeutics·P GinèsM Guevara
Dec 24, 2005·Der Anaesthesist·I KürerW Boemke
Dec 7, 2002·European Journal of Gastroenterology & Hepatology·Carlo AlessandriaMario Rizzetto
Feb 21, 2006·World Journal of Gastroenterology : WJG·Alexander L Gerbes, Veit Gulberg
Feb 24, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Richard Moreau, Didier Lebrec
Sep 1, 2004·Alimentary Pharmacology & Therapeutics·R Moreau, D Lebrec
Sep 30, 2010·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Claire FrancozFrançois Durand

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.